The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2002
DOI: 10.1385/endo:17:3:215
|View full text |Cite
|
Sign up to set email alerts
|

Growth Hormone-Releasing Hormone and Gonadotropin-Releasing Hormone Stimulate Nitric Oxide Production in 17β-Estradiol-Primed Rat Anterior Pituitary Cells

Abstract: It was reported that neuronal nitric oxide synthase (nNOS) was expressed only in gonadotrophs and folliculo-stellate cells in the anterior lobe of the pituitary gland. However, recent studies have demonstrated the occurrence of nNOS in the somatotrophs and lactotrophs. In the present study, we investigated effects of growth hormone-releasing hormone (GHRH), gonadotropin-releasing hormone (GnRH), and 17beta-estradiol on nitric oxide (NO) release in cultured rat anterior pituitary cells in vitro. The NO2- level … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
9
0

Year Published

2003
2003
2018
2018

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(9 citation statements)
references
References 26 publications
0
9
0
Order By: Relevance
“…The effectors of vascular flow change may be pericytes, which display long contractile cytoplasmic processes embracing the endothelial tube of portal capillary vessels (30). These express receptors for diffusible vascular signaling factors (31), such as nitric oxide (32), which is synthesized by GH cells (33,34).…”
Section: Discussionmentioning
confidence: 99%
“…The effectors of vascular flow change may be pericytes, which display long contractile cytoplasmic processes embracing the endothelial tube of portal capillary vessels (30). These express receptors for diffusible vascular signaling factors (31), such as nitric oxide (32), which is synthesized by GH cells (33,34).…”
Section: Discussionmentioning
confidence: 99%
“…Based on the route of administration, this antagonist could alter different hypothalamic systems given that dopamine is involved in the regulation of various endocrine loops including the GnRH and somatostatin producing neurons of the hypothalamus (McMahon et al 1998;West et al 1997;Hileman and Jackson 1999;Tortonese 1999). Thus, considering that GnRH or GHRH which is influenced by somatostatin activates nNOS in pituitary cells (Chen et al 1999;Ferrini et al 2001;Tsumori et al 2002), we cannot totally exclude the possibility that the haloperidol effects which we have observed on pituitary nNOS-positive cells reflect the indirect effects of hypothalamic systems.…”
Section: Discussionmentioning
confidence: 99%
“…Statistical analysis was performed by a of cell types. In the pituitary, different endocrine cells express neuronal NO synthase (nNOS; Hokfelt et al 1994, Andric et al 2001, Tsumori et al 2002, and vascular endothelial cells express endothelial NO synthase (eNOS; Garcia-Cardena et al 1996). Both nNOS and eNOS produce NO using L-arginine as substrate.…”
Section: Regulation Of Blood Flowmentioning
confidence: 99%
“…Both nNOS and eNOS produce NO using L-arginine as substrate. Various peptides, including hypothalamic neuropeptides and pituitary hormones, can modulate NOS activity and vascular tone (Boger 1999, Tsumori et al 2002. NO, in turn, can modulate secretory activity and hormone output (Gonzalez-Hernandez & Gonzalez 2000).…”
Section: Regulation Of Blood Flowmentioning
confidence: 99%
See 1 more Smart Citation